血管生成(angiogenesis)即新生血管的形成,是机体生长、发育、生殖和创伤修复所需的基本生理过程,也是对局部组织缺血的反应[1].肿瘤血管生成就是新生血管在肿瘤现有血管上形成的过程[2].

[1] LI W W. Tumor angiogenesis:molecular pathology,therapeutic targeting,and imaging. 2000(10). doi:10.1016/S1076-6332(0)80629-7
[2] FOLKMAN J. What is evidence that tumors are angiogenesis dependent?. 1990(1). doi:10.1093/jnci/82.1.4
[3] DALDRUP-LINK H E, SIMON G H, BRASCH R C. Imaging of tumor angiogenesis:current approaches and future prospects. 2006(21). doi:10.2174/138161206777698774
[4] MILES K A, LEGGETT D A, KELLEY B B. In vivo measurements of neovascularization of liver matastases using perfusion CT, 1998(843)
[5] MILES K A. Functional CT imaging in oncology, 2003(z5)
[6] TATEISHI U, NISHIHARA H, WATANABE S. Tumor angiogenesis and dynamic CT in lung adenocarcinoma:radiologic-pathologic correlation. 2001(1). doi:10.1097/00004728-200101000-00004
[7] KWAK B K, SHIM H J, PARK E S. Hepatocellular carcinoma:correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast enhanced computed tomography. 2001(8). doi:10.1097/00004424-200108000-00008
[8] WANG Z Q, LU G M, LI J S. The comparative study of tumor angiogenesis and CT enhancement in pancreatic carcinoma. 2004(3). doi:10.1016/S0720-048X(3)00171-2
[9] WANG J H, QIU M P, WANG P J. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. 2006(5). doi:10.2214/AJR.04.1408
[10] CENIC A, NABAVI D G, CRAEN R A. A CT method to measure hemodynamics in brain tumors:validation and application of cerebral blood flow maps, 2000(3)
[11] SWENSEN S J, VIGGIANO R W, MIDTHUN D E. Lung nodule enhancement at CT:multicenter study. 2000(1)
[12] 周华, 张敏鸣, 肖圣祥. 动态增强CT功能成像评价肺癌肿瘤血管生成的研究. 中华放射学杂志2006(2)
[13] 张敏鸣, 周华, 邹煜. 动态增强CT对孤立性肺结节的定量研究. 中华放射学杂志2004(3)
[14] 文利, 丁仕义, 牟伟. 肝细胞癌CT灌注参数与微血管密度的相关性研究. 中华放射学杂志2005(3)
[15] KAN Z X, PHONGKITKARUN S, KOBAYASHI S. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. 2005(1). doi:10.1148/radiol.2363041293
[16] BRASCH R C, LI K C, HUSBAND J E. In vivo monitoring of tumor angiogenesis with MR imaging. 2000(10). doi:10.1016/S1076-6332(0)80630-3
[17] KUHL C K, MIELCARECK P, KLASCHIK S. Dynamic breast MR imaging:are signal intensity time course data useful for differential diagnosis of enhancing lesions?. 1999(1)
[18] KNOPP M V, WEISS E, SINN H P. 3.0.CO, 2-7.aspx">Pathophysiologic basis of contrast enhancement in breast tumor. 1999(3). doi:10.1002/(SICI)1522-2586(199909)10:3&lt, 260::AID-JMRI6&gt, 3.0.CO, 2-7
[19] SCHAEFERA J F, VINCENT S, JOACHIM V. Solitary p-ulmonary nodules:association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. 2006(1). doi:10.1016/j.lungcan.2006.03.010
[20] WANG J, CHEN L T, TSANG Y M. Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic age-nt:a preliminary study. 2004(3)
[21] IKEDA O, NISHIMURA R, MIYAYAMA H. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging:comparison of plasma vascular endothelial growth factor,hemodynamic,and pharmacokinetic parameters. 2004(4). doi:10.1080/02841850410005372
[22] PRINCIPI M, ITALIANI M, GUIDUCCI A. Perfusion MRI in the evaluation of the relation-ship between tumour growth,necrosis and angiogenesis in glioblastomas and grade 1 meningiomas. 2003(4)
[23] TRISTAN B, HISATAKA K, MARTIN B. Macromolecular MRI contrast agents for imaging tumor angiogenesis. 2006(3). doi:10.1016/j.ejrad.2006.06.025
[24] DALDRUP H, SHAMES D M, WENDLAND M. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade:comparison of macromolecular and small-molecular contrast media, 1998(4)
[25] TURETSCHEK K, PREDA A, NOVIKOV V. Tumor microvascular changes in antiangiogenic treatment:assessment by magnetic resonance contrast media of different molecular weights. 2004(1). doi:10.1002/jmri.20049
[26] YAMADA I, AUNG W, HIMENO Y. Diffusion coefficients in abdominal organs and hepetic lesion:evaluation with intravoxel incoherent motion echoplanar MR imaging. 1999(3)
[27] WINTER P M, CARUTHERS S D, KASSNER A. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. 2003(18)
[28] SCHMIEDER A H, WINTER P M, CARUTHERS S D. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. 2005(3). doi:10.1002/mrm.20391
[29] SIPKINS D A, CHERESH D A, KAZEMI M R. Detection of tumor angiogenesis in vivo by alpha v beta3-targeted magnetic resonance imaging. 1998(5). doi:10.1038/nm0598-623
[30] ANDERSON S A, RADER R K, WESTLIN W F. Magnetic resonance contrast enhancementof neovasculature with alpha(v)beta(3)-targeted nanoparticles. 2000(3). doi:10.1002/1522-2594(200009)44:3&lt, 433::AID-MRM14&gt, 3.0.CO, 2-9
[31] GUCCIONE S, LI-KING C P, BEDNARSKI M D. Molecular imaging and the-rapy directed at the neovasculature in pathologies.How imaging can be incorporated into vascular-targeted delivery systems to generate active therapeutic agents. 2004(5). doi:10.1109/MEMB.2004.1360408